These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 11454917

  • 1. Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo.
    Okano S, Nagaya H, Ikeura Y, Natsugari H, Inatomi N.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):559-64. PubMed ID: 11454917
    [Abstract] [Full Text] [Related]

  • 2. Peripheral activity of a new NK1 receptor antagonist TAK-637 in the gastrointestinal tract.
    Venkova K, Sutkowski-Markmann DM, Greenwood-Van Meerveld B.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1046-52. PubMed ID: 11861814
    [Abstract] [Full Text] [Related]

  • 3. Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distention in rabbits.
    Okano S, Ikeura Y, Inatomi N.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):925-31. PubMed ID: 11861799
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of tachykinin NK(1) and NK(2) receptors in colonic sensitivity and stress-induced defecation in gerbils.
    Kakol-Palm D, Brusberg M, Sand E, Larsson H, Martinez V, Johansson A, von Mentzer B, Påhlman I, Lindström E.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):123-31. PubMed ID: 18234189
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of TAK-637, a tachykinin NK1-receptor antagonist, on lower urinary tract function in cats.
    Kamo I, Doi T.
    Jpn J Pharmacol; 2001 Jun 17; 86(2):165-9. PubMed ID: 11459118
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological evaluation of a novel corticotropin-releasing factor 1 receptor antagonist T-3047928 in stress-induced animal models in a comparison with alosetron.
    Itomi Y, Tanaka T, Matsushita K, Kawamura T, Kojima T, Aso K, Matsumoto-Okano S, Tsukimi Y.
    Neurogastroenterol Motil; 2020 May 17; 32(5):e13795. PubMed ID: 31970891
    [Abstract] [Full Text] [Related]

  • 11. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
    Kadowaki M, Nagakura Y, Tomoi M, Mori J, Kohsaka M.
    J Pharmacol Exp Ther; 1993 Jul 17; 266(1):74-80. PubMed ID: 8331576
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
    Funatsu T, Takeuchi A, Hirata T, Keto Y, Akuzawa S, Sasamata M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):190-5. PubMed ID: 17658508
    [Abstract] [Full Text] [Related]

  • 14. Possible site of action of TAK-637, a tachykinin NK(1) receptor antagonist, on the micturition reflex in guinea pigs.
    Kamo I, Imai S, Okanishi S, Doi T.
    Eur J Pharmacol; 2000 Aug 04; 401(2):235-40. PubMed ID: 10924932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. EFFECT OF 5-HT3 ANTAGONIST ONDANSETRON ON WRAP-RESTRAINT AND CONDITIONED EMOTIONAL STRESS INDUCED DEFECATION.
    Karan RS, Saha L, Handu SS, Bhargava VK.
    Indian J Physiol Pharmacol; 1999 Jan 04; 43(1):129-32. PubMed ID: 27093752
    [Abstract] [Full Text] [Related]

  • 18. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.
    Kishibayashi N, Miwa Y, Hayashi H, Ishii A, Ichikawa S, Nonaka H, Yokoyama T, Suzuki F.
    J Med Chem; 1993 Oct 29; 36(22):3286-92. PubMed ID: 8230119
    [Abstract] [Full Text] [Related]

  • 19. Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells.
    Keita AV, Söderholm JD, Ericson AC.
    Neurogastroenterol Motil; 2010 Jul 29; 22(7):770-8, e221-2. PubMed ID: 20149111
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.